Vyvanse is a Schedule II controlled substance, as its use can lead to addiction, dependence, abuse, and harm
Marston is also managing the separate GLP-1 stomach-paralysis MDL, where key bellwether cases are expected to be prioritized first and could serve as a guide for how the vision-loss claims unfold
The DNA methylation is an epigenetic mechanism, able to modify the expression of specific genes without changing the DNA sequence
Rapid-acting analogs aim for quick meal coverage, while older formulations and basal insulins follow distinct curves
2024 FDA Developments Several important FAA and FDA actions occurred in 2024: In January 2024, tirzepatide (Zepbound, Mounjanaro) was added to the FAAs Conditionally Acceptable Weight Loss Medications category, but medical certification required Special Issuance
Peptide therapy promotes hormonal and metabolic health by decreasing free androgens, improving estrogen balance, and reducing hyperinsulinemia to restore ovulation and regular menstrual cycles